Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Purpura, Thrombotic Thrombocytopenic 1

Interventions

Cyclophosphamide 909 Carboplatin 787 pembrolizumab 744 Paclitaxel 742 Cisplatin 709 Bevacizumab 706 Gemcitabine 619 Docetaxel 579 Rituximab 548 Radiotherapy 541 Dexamethasone 511 Nivolumab 488 Doxorubicin 444 Fluorouracil 392 Capecitabine 376 Etoposide 358 Pemetrexed 337 Cytarabine 335 Oxaliplatin 333 Lenalidomide 328 Prednisone 326 fludarabine phosphate 316 Erlotinib Hydrochloride 314 Trastuzumab 300 Leucovorin 299 fludarabine 296 Vincristine 287 Filgrastim 284 Bortezomib 284 Cetuximab 276

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Has results × caplacizumab × Clear all

NCT02553317 2023-04-05

HERCULES

Sanofi

Phase 3 Completed

145 enrolled 20 charts 1 FDA

Purpura, Thrombotic Thrombocytopenic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡